Gilead pulls 2 cancer accelerated approvals as changing lymphoma landscape disrupts confirmatory trial

Gilead pulls 2 cancer accelerated approvals as changing lymphoma landscape disrupts confirmatory trial
aliu
Mon, 01/24/2022 – 11:34